The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost effectiveness of adjuvant pembrolizumab after nephrectomy for RCC: Insights for patient selection from a Markov model.
 
Vidit Sharma
No Relationships to Disclose
 
Kevin M Wymer
No Relationships to Disclose
 
Daniel D. Joyce
No Relationships to Disclose
 
James P. Moriarty
No Relationships to Disclose
 
Bijan J Borah
Consulting or Advisory Role - Boehringer Ingelheim; Exact Sciences
 
R. Houston Thompson
No Relationships to Disclose
 
Brian Addis Costello
Consulting or Advisory Role - Exelixis (Inst)
Speakers' Bureau - Clinical Care Options/NCCN (Inst)
Research Funding - GlaxoSmithKline/Novartis (Inst)
 
Bradley C. Leibovich
No Relationships to Disclose
 
Stephen A. Boorjian
Consulting or Advisory Role - ArTara Therapeutics; FerGene; Ferring